UPDATE: BTIG Starts BioAtla Inc. (BCAB) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
UPDATE: Credit Suisse Starts BioAtla Inc. (BCAB) at Outperform
January 11, 2021 5:01 AM EST(Updated - January 11, 2021 6:23 AM EST)
Credit Suisse analyst Tiago Fauth initiates coverage on BioAtla Inc. (NASDAQ: BCAB) with a Outperform rating and a price target of $49.00.
The analyst comments "The companys two lead proprietary programs targeting AXL (BA3011) and ROR2 (BA3021) are antibody-drug conjugates (ADC) designed with BCABs proprietary conditionally active biologics (CAB) technology. CAB molecules have... More
UPDATE: Jefferies Starts BioAtla Inc. (BCAB) at Buy Ahead of Two Separate Phase 2 Readouts
January 11, 2021 4:43 AM EST(Updated - January 11, 2021 8:52 AM EST)
Jefferies analyst Biren Amin initiates coverage on BioAtla Inc. (NASDAQ: BCAB) with a Buy rating and a price target of $51.00 ahead of Ph2 interim readouts in H2' 21. Jefferies was joint book-running manager in BCAB's... More
JPMorgan Starts BioAtla Inc. (BCAB) at Overweight
January 11, 2021 4:42 AM ESTJPMorgan initiates coverage on BioAtla Inc. (NASDAQ: BCAB) with a Overweight rating and a price target of $45.00.
For an analyst ratings summary and ratings history on BioAtla Inc. click here. For more ratings news on BioAtla Inc. click here.
Shares of BioAtla Inc. closed at $38.25 yesterday.
... More